These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 16980083

  • 1. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A, Mengelle C, Basse G, Ribes D, Kamar N, Muscari F, Lavayssière L, Suc B, Esposito L, Peron JM, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [Abstract] [Full Text] [Related]

  • 2. Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction.
    Mengelle C, Abravanel-Legrand F, Kamar N, Alain S, Basse G, Pillet A, Lavayssière L, Suc B, Izopet J, Rostaing L.
    Exp Clin Transplant; 2006 Dec; 4(2):537-43. PubMed ID: 17238855
    [Abstract] [Full Text] [Related]

  • 3. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [Abstract] [Full Text] [Related]

  • 4. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M, Loginov R, Piiparinen H, Halme L, Höckerstedt K, Lautenschlager I.
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [Abstract] [Full Text] [Related]

  • 5. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Gerna G, Lilleri D, Zecca M, Alessandrino EP, Baldanti F, Revello MG, Locatelli F.
    Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949
    [Abstract] [Full Text] [Related]

  • 6. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N, Mengelle C, Yahyaoui S, Sandres-Sauné K, Durand D, Izopet J, Rostaing L.
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [Abstract] [Full Text] [Related]

  • 7. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM, Milpied N, Coste-Burel M, Richet B, Moreau P, Harousseau JL, Billaudel S.
    Bone Marrow Transplant; 1995 Apr; 15(4):611-7. PubMed ID: 7655389
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G, Percivalle E, Baldanti F, Sarasini A, Zavattoni M, Furione M, Torsellini M, Revello MG.
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M.
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G, Esposito L, Mengelle C, Kamar N, Ribes D, Lavayssière L, Pillet A, Suc B, Barange K, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E, Henriot S, Zachary P, Freitag R, Fuchs A, Fritsch S, Risch S, Meyer N, Caillard S, Lioure B, Stoll-Keller F.
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G, Lilleri D.
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [Abstract] [Full Text] [Related]

  • 16. Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation.
    Lao WC, Lee D, Burroughs AK, Lanzani G, Rolles K, Emery VC, Griffiths PD.
    J Med Virol; 1997 Mar; 51(3):152-8. PubMed ID: 9139077
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y, Ito Y, Kaneko K, Shibata-Watanabe Y, Tainaka T, Sumida W, Nakamura T, Kamei H, Kiuchi T, Ando H, Kimura H.
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
    Chen F, He Z, Pan S, Ning F, Wang Q, Xiao Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.